Covaxinís efficacy expected to be more than 90%: Dr OP Kalra

Vice-Chancellor of Pt BD Sharma University of Health Sciences, (Rohtak), OP Kalra during a press conference on November 18 said that the third phase of Covaxin will start from November 20. "200 volunteers will be administered the vaccine early to study its anti-bodies response. There will be 2 doses; 2nd dose to be given 28 days after the first dose. Vaccine's efficacy is expected to be more than 90%," he said.